Clever Leaves Holdings Inc. (CLVR) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Clever Leaves Holdings Inc. (CLVR) trades at $0.0001 with AI Score 47/100 (Grade C). Clever Leaves Holdings Inc. is a global cannabis company operating through cannabinoid and non-cannabinoid segments. Sector: Healthcare.
Price as of Jul 20, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for CLVR: CLVR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLVR against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CLVR: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Clever Leaves Holdings Inc. (CLVR) Healthcare & Pipeline Overview
Clever Leaves Holdings Inc., founded in 2017, operates in the global cannabis market, focusing on cannabinoid and non-cannabinoid products. With a presence in both international cannabinoid markets and the U.S. nutraceutical sector, the company faces challenges typical of the evolving cannabis industry, including regulatory hurdles and intense competition.
What Is the Investment Thesis for CLVR?
Investing in Clever Leaves Holdings Inc. presents a high-risk, high-reward scenario. The company operates in the rapidly evolving cannabis industry, offering potential for significant growth but also exposing investors to substantial risks. Key value drivers include the expansion of its international cannabinoid operations and the growth of its nutraceutical business in the U.S. However, the company's negative profit margin of -102.8% and OTC market listing raise concerns about its financial stability and liquidity. Growth catalysts include potential regulatory changes in key markets and successful product launches. Investors should carefully consider the company's financial position, competitive landscape, and regulatory environment before investing. The high beta of 4.48 indicates significant volatility.
Based on FMP financials and quantitative analysis
CLVR Key Highlights
- Clever Leaves operates in the Cannabinoid segment, focusing on cultivation, extraction, and distribution of cannabis products internationally.
- The company's Non-Cannabinoid segment formulates and sells nutraceuticals and wellness products in the United States.
- Clever Leaves was founded in 2017 and is based in Boca Raton, Florida.
- The company has a gross margin of 37.6%.
- Clever Leaves has 296 employees.
Who Are CLVR's Competitors?
CLVR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.14 | +0.21% | $40.3M | 61 |
| MNNGF Baijin Life Science Holdings Limited | $0.07 | +0.00% | $58.0M | 63 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| SHIEF Shield Therapeutics plc | $0.08 | +0.00% | $84.8M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLVR's Key Strengths?
- Diversified product portfolio (cannabinoid and non-cannabinoid).
- International presence in key cannabis markets.
- Established distribution network in the U.S. nutraceutical market.
- Expertise in cannabis cultivation and extraction.
What Are CLVR's Weaknesses?
- Negative profit margin.
- High beta indicating significant volatility.
- OTC market listing raises liquidity concerns.
- Dependence on regulatory changes in the cannabis industry.
What Could Drive CLVR Stock Higher?
- Potential regulatory changes in key international markets could open new opportunities for cannabinoid product sales.
- Successful product launches in the U.S. nutraceutical market could drive revenue growth.
- Expansion of the company's distribution network in the United States.
- Strategic partnerships and acquisitions to expand market reach.
- Research and development efforts to create innovative and differentiated products.
What Are the Key Risks for CLVR?
- Financial-distress signal — its Altman Z-Score of -10.11 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-55.4%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Evolving and uncertain regulatory landscape in the cannabis industry.
- Intense competition in both the cannabis and nutraceutical markets.
- Fluctuations in commodity prices could impact profitability.
- Product recalls or liability claims could damage the company's reputation and financial performance.
- Limited access to capital due to OTC market listing.
What Are the Growth Opportunities for CLVR?
- Expansion of Cannabinoid Operations: Clever Leaves has the opportunity to expand its cannabinoid operations in international markets. As more countries legalize cannabis for medicinal or recreational use, the company can leverage its existing infrastructure and expertise to enter new markets and increase its market share. The global cannabis market is projected to reach $57 billion by 2027, offering significant growth potential for Clever Leaves.
- Growth in the U.S. Nutraceutical Market: The company can capitalize on the growing demand for nutraceuticals and wellness products in the United States. By expanding its product portfolio and distribution network, Clever Leaves can increase its sales and market share in this segment. The U.S. nutraceutical market is estimated to be worth $80 billion, providing a substantial opportunity for Clever Leaves.
- Strategic Partnerships and Acquisitions: Clever Leaves can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with other companies in the cannabis or nutraceutical industries, the company can gain access to new technologies, products, and markets. Acquisitions can also help Clever Leaves consolidate its position in key markets and increase its economies of scale.
- Product Innovation and Differentiation: Clever Leaves can invest in research and development to create innovative and differentiated products that meet the evolving needs of consumers. By developing unique formulations and delivery methods, the company can gain a competitive advantage and increase its brand recognition. This includes exploring new cannabinoid-based therapies and novel nutraceutical products.
- Regulatory Changes and Market Liberalization: Changes in regulations and market liberalization can create new opportunities for Clever Leaves. As more countries and states legalize cannabis, the company can expand its operations and access new markets. Monitoring and adapting to regulatory changes will be crucial for Clever Leaves to capitalize on these opportunities. This includes advocating for favorable regulations and participating in industry discussions.
What Opportunities Does CLVR Have?
- Expansion into new international cannabis markets.
- Growth in the U.S. nutraceutical market.
- Strategic partnerships and acquisitions.
- Product innovation and differentiation.
What Threats Does CLVR Face?
- Evolving and uncertain regulatory landscape.
- Intense competition in the cannabis and nutraceutical industries.
- Fluctuations in commodity prices.
- Potential for product recalls or liability claims.
What Are CLVR's Competitive Advantages?
- International presence in the cannabinoid market.
- Diversified product portfolio across cannabinoid and non-cannabinoid segments.
- Established distribution network in the United States.
- Expertise in cannabis cultivation and extraction.
What Does CLVR Do?
Clever Leaves Holdings Inc., established in 2017, is a cannabis company headquartered in Boca Raton, Florida. The company operates through two primary segments: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is involved in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products on a global scale. This includes various cannabis-derived products targeted at medicinal and wellness applications. The Non-Cannabinoid segment focuses on the formulation, manufacturing, marketing, selling, and distribution of nutraceuticals, natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. These products are primarily sold to mass retailers, specialty and health retailers, and distributors within the United States. Clever Leaves aims to leverage its international presence and diversified product portfolio to capture a significant share of the growing cannabis and wellness markets. However, the company faces challenges related to regulatory complexities, market competition, and achieving profitability.
What Products and Services Does CLVR Offer?
- Cultivates cannabis plants for cannabinoid extraction.
- Extracts cannabinoids from cannabis plants.
- Manufactures cannabinoid-based products.
- Commercializes and distributes cannabinoid products internationally.
- Formulates nutraceutical and wellness products.
- Markets and sells nutraceutical products in the United States.
- Distributes nutraceuticals to mass retailers, specialty stores, and distributors.
How Does CLVR Make Money?
- Cultivation and extraction of cannabinoids for sale to manufacturers and distributors.
- Manufacturing and sale of cannabinoid-based products to consumers and businesses.
- Formulation, manufacturing, and sale of nutraceutical and wellness products in the U.S.
- Distribution through mass retailers, specialty stores, and distributors.
What Industry Does CLVR Operate In?
Clever Leaves operates within the rapidly expanding cannabis and nutraceutical industries. The nutraceuticals market is also experiencing growth, fueled by rising consumer awareness of health and wellness. However, both industries are highly competitive and subject to evolving regulations. Clever Leaves competes with other cannabis producers and nutraceutical companies, facing challenges related to market access, product differentiation, and regulatory compliance.
Who Are CLVR's Key Customers?
- Cannabis product manufacturers and distributors.
- Consumers seeking cannabinoid-based products.
- Mass retailers in the United States.
- Specialty and health retailers in the United States.
F-Score 3/9Financial Health
Clever Leaves Holdings Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -10.11 places it in the distress zone, a signal of elevated financial risk.
ROE -55%Key Financial Metrics
Return on equity for Clever Leaves Holdings Inc. stands at -55.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -57.3%, showing how much profit it generates from its asset base. A current ratio of 2.40 indicates the company holds enough short-term assets to cover its near-term obligations.
CLVR Valuation & Market Position
Relative to its peer group, CLVR's quantitative score of 47/100 is below the peer average of 62/100.
CLVR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Clever Leaves has shown positive insider activity, signaling confidence from management in the company's direction.
- Recent partnerships in the cannabis sector have enhanced its distribution capabilities, broadening market reach.
- Community sentiment has turned optimistic, with discussions highlighting potential growth in international markets.
- The company’s focus on sustainable practices resonates well with environmentally conscious investors, boosting its appeal.
Bear Case
- Concerns over regulatory challenges in the cannabis industry have dampened investor enthusiasm recently.
- Market sentiment has been mixed, with some community members expressing skepticism about long-term profitability.
- Recent earnings reports indicated slower growth than expected, raising doubts about operational efficiency.
- Increased competition in the cannabis space is putting pressure on market share, causing apprehension among investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CLVR Latest News
No recent news available for CLVR.
CLVR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLVR.
Price Targets
Wall Street price target analysis for CLVR.
CLVR MoonshotScore
What does this score mean?
The MoonshotScore rates CLVR 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Andres Fajardo
Unknown
Information about Andres Fajardo's specific background and career history is not available in the provided data. Therefore, a detailed biography cannot be provided. His professional experience and educational background are unknown.
Track Record: Specific achievements and strategic decisions made by Andres Fajardo as CEO of Clever Leaves Holdings Inc. are not detailed in the provided data. Therefore, a comprehensive track record cannot be assessed.
CLVR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Clever Leaves may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance compared to companies listed on major exchanges like the NYSE or NASDAQ. Trading on the OTC Other tier often implies higher risk and requires increased due diligence.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Increased regulatory scrutiny.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor the company's news and press releases for any red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC trading.
- Company has been in operation since 2017.
- Operates in a regulated industry (cannabis and nutraceuticals).
- Has a diversified product portfolio.
- Maintains a physical headquarters in Boca Raton, Florida.
What Investors Ask About Clever Leaves Holdings Inc. (CLVR) — Healthcare
What does the AI Score mean for CLVR?
CLVR holds an AI Score of 47/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Clever Leaves Holdings Inc. is a global cannabis company operating through cannabinoid and non-cannabinoid segments. The company cultivates, extracts, manufactures, and distributes cannabinoid …
What does Clever Leaves Holdings Inc. do?
Clever Leaves Holdings Inc. operates as a global cannabis company with two segments: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment focuses on the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, and distributes nutraceutical and wellness products in the United States.
What are the main risks for CLVR?
Clever Leaves faces several key risks, including the evolving and uncertain regulatory landscape in the cannabis industry, intense competition in both the cannabis and nutraceutical markets, fluctuations in commodity prices, and the potential for product recalls or liability claims. The company's OTC market listing also raises concerns about liquidity and access to capital. Investors should carefully consider these risks before investing in Clever Leaves.
How does Clever Leaves Holdings Inc. navigate regulatory approval processes?
As a cannabis company, Clever Leaves Holdings Inc. faces complex regulatory approval processes in various jurisdictions. The company must comply with regulations related to cultivation, extraction, manufacturing, and distribution of cannabis products. Specific details regarding Clever Leaves' FDA/EMA regulatory track record, pending approvals, and compliance strategy are not available in the provided data. However, the company's ability to navigate these regulatory hurdles will be crucial for its long-term success.
How does Clever Leaves Holdings Inc. manage its supply chain for cannabis production?
Managing the supply chain is critical for Clever Leaves to ensure consistent product quality and availability. This includes sourcing raw materials, managing cultivation and extraction processes, and ensuring efficient distribution. Specific details about Clever Leaves' supply chain management practices are not available in the provided data. However, the company's ability to effectively manage its supply chain will be essential for maintaining its competitive advantage and meeting customer demand.
What are the key factors to evaluate for CLVR?
Clever Leaves Holdings Inc. (CLVR) holds an AI score of 47/100 (low). Not financial advice.
How frequently does CLVR data refresh on this page?
CLVR's price was last updated on Jul 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CLVR's recent stock price performance?
Clever Leaves Holdings Inc. (CLVR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio (cannabinoid and non-cannabinoid). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CLVR overvalued or undervalued right now?
Clever Leaves Holdings Inc. (CLVR) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited to the provided data.
- AI analysis is pending, which could provide further insights.